19:50 EST Bluebird Bio (BLUE) trading halted, news pending
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BLUE:
- Largest borrow rate increases among liquid names
- Bluebird Bio presents long-term data on LYFGENIA gene therapy for SCD
- CMS to work with Vertex, blubird to improve access to therapies, Reuters reports
- Bluebird Bio announces 1-for-20 reverse stock split
- Bluebird Bio participates in CMMI Cell and Gene Therapy Access Model